PD-L1 stimulation can promote proliferation and survival of leukemic cells by influencing glucose and fatty acid metabolism in acute myeloid leukemia
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 1 online resource.
- Sprache
-
Englisch
- Erschienen in
-
PD-L1 stimulation can promote proliferation and survival of leukemic cells by influencing glucose and fatty acid metabolism in acute myeloid leukemia ; volume:23 ; number:1 ; day:16 ; month:5 ; year:2023 ; pages:1-9 ; date:12.2023
BMC cancer ; 23, Heft 1 (16.5.2023), 1-9, 12.2023
- Urheber
-
Soltani, Mojdeh
Ghanadian, Mustafa
Ghezelbash, Behrooz
Shokouhi, Abolfazl
Zamyatnin, Andrey A.
Bazhin, Alexandr V.
Ganjalikhani-Hakemi, Mazdak
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12885-023-10947-7
- URN
-
urn:nbn:de:101:1-2023090812563771626436
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:50 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Soltani, Mojdeh
- Ghanadian, Mustafa
- Ghezelbash, Behrooz
- Shokouhi, Abolfazl
- Zamyatnin, Andrey A.
- Bazhin, Alexandr V.
- Ganjalikhani-Hakemi, Mazdak
- SpringerLink (Online service)
Ähnliche Objekte (12)
Anti-TIGIT antibody improves PD-L1 blockade through myeloid and Treg cells
Targeting PD-1/PD-L1 pathway in myelodysplastic syndromes and acute myeloid leukemia
Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response
Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors
Publisher Correction: Anti-TIGIT antibody improves PD-L1 blockade through myeloid and Treg cells
Author Correction: Anti-TIGIT antibody improves PD-L1 blockade through myeloid and Treg cells
STAT5 promotes PD-L1 expression by facilitating histone lactylation to drive immunosuppression in acute myeloid leukemia
PD-L1 Expression als Prognosemarker beim Endometriumkarzinom
Factors correlating the expression of PD-L1
Optimized PD-L1 scoring of gastric cancer
Prognostic value of soluble PD-L1 and exosomal PD-L1 in advanced gastric cancer patients receiving systemic chemotherapy
Modulating PD-L1 expression in multiple myeloma: an alternative strategy to target the PD-1/PD-L1 pathway
Anti-TIGIT antibody improves PD-L1 blockade through myeloid and Treg cells
Targeting PD-1/PD-L1 pathway in myelodysplastic syndromes and acute myeloid leukemia
Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response
Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors
Publisher Correction: Anti-TIGIT antibody improves PD-L1 blockade through myeloid and Treg cells
Author Correction: Anti-TIGIT antibody improves PD-L1 blockade through myeloid and Treg cells
STAT5 promotes PD-L1 expression by facilitating histone lactylation to drive immunosuppression in acute myeloid leukemia
PD-L1 Expression als Prognosemarker beim Endometriumkarzinom
Factors correlating the expression of PD-L1
Optimized PD-L1 scoring of gastric cancer
Prognostic value of soluble PD-L1 and exosomal PD-L1 in advanced gastric cancer patients receiving systemic chemotherapy
Modulating PD-L1 expression in multiple myeloma: an alternative strategy to target the PD-1/PD-L1 pathway
Anti-TIGIT antibody improves PD-L1 blockade through myeloid and Treg cells
Targeting PD-1/PD-L1 pathway in myelodysplastic syndromes and acute myeloid leukemia
Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response
Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors
Publisher Correction: Anti-TIGIT antibody improves PD-L1 blockade through myeloid and Treg cells
Author Correction: Anti-TIGIT antibody improves PD-L1 blockade through myeloid and Treg cells
STAT5 promotes PD-L1 expression by facilitating histone lactylation to drive immunosuppression in acute myeloid leukemia
PD-L1 Expression als Prognosemarker beim Endometriumkarzinom
Factors correlating the expression of PD-L1
Optimized PD-L1 scoring of gastric cancer
Prognostic value of soluble PD-L1 and exosomal PD-L1 in advanced gastric cancer patients receiving systemic chemotherapy